REG1 is an anticoagulation system.

It involves inhibition of Factor IXa.[1]


  1. Becker RC, Chan MY (December 2009). "REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis". Curr. Opin. Mol. Ther. 11 (6): 707–15. PMID 20072947.
This article is issued from Wikipedia - version of the 1/29/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.